• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险预测指标、药物、同型半胱氨酸及同型半胱氨酸代谢途径基因多态性与CVA/中风的差异内涵

The Connotation of Variances in the Risk Predictors, Medications, Homocysteine, and Homocysteine Pathway Gene Polymorphisms with CVA/Stroke.

作者信息

Masud Rizwan, Khan Aleem Ul Haq, Anjum Aiman Farogh, Jawwad Ghazala, Azeem Zahid, Baqai Haider Zaigham, Hashmi Shoaib Naiyar

机构信息

Department of Physiology, CMH Kharian Medical College, Kharian, Pakistan.

Department of Biochemistry, CMH Kharian Medical College, Kharian, Pakistan.

出版信息

Glob Med Genet. 2020 Dec;7(4):113-120. doi: 10.1055/s-0041-1722884. Epub 2021 Feb 9.

DOI:10.1055/s-0041-1722884
PMID:33693444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7938795/
Abstract

Cerebrovascular accidents (CVAs) are vascular multifactorial, multigenic ailments with intricate genetic, environmental risk influences. The present study aimed to establish affiliation of CVAs/stroke with blood parameters, differences in prescribed drugs consumption, and with differences in homocysteine pathway genes polymorphisms. The participants in study included controls  = 251, transient ischemic attack (TIA) patients  = 16, and stroke cases  = 122, respectively, (total participants,  = 389). The analyzed single nucleotide polymorphisms (SNPs) included C677T(rs1801133), A1298C(rs1801131) of methylene tetrahydrofolate reductase ( ), A2756G(rs1805087) of methyl tetrahydrofolate homocysteine methyltransferase/methionine synthase ( ), and the A192G(rs662) of paraoxonase 1( ) genes, all validated by tetra-primer allele refractory mutation system polymerase chain reaction (T-ARMS-PCR). The insertion deletion (I/D; rs4646994) polymorphism in angiotensin converting enzyme ( ) gene was analyzed using routine PCR. All studied traits were scrutinized through analysis of variance (ANOVA), and later through regression analysis. Through ANOVA and multiple comparison, there was association of CVA with serum homocysteine, cholesterol, and with diastolic blood pressure readings. When data was subjected to regression, serum homocysteine and diastolic blood pressure (significant through ANOVA), as well as two additional traits, high-density lipoproteins (HDL), and rs1801133 MTHFR SNP sustained statistical significance and noteworthy odds in relation to CVA and stroke. The ailments affecting cerebral vasculature are mutifactorial, whereby genes, proteins, and environmental cues all exert cumulative effects enhancing CVA risk. The current study emphasizes that SNPs and variation in circulating biomarkers can be used for screening purposes and for reviewing their effects in stroke/CVA-linked risk progression.

摘要

脑血管意外(CVA)是具有复杂遗传和环境风险影响的血管多因素、多基因疾病。本研究旨在确定CVA/中风与血液参数、处方药消费差异以及同型半胱氨酸途径基因多态性差异之间的关联。研究参与者分别包括对照组 = 251例、短暂性脑缺血发作(TIA)患者 = 16例和中风病例 = 122例(总参与者,= 389例)。分析的单核苷酸多态性(SNP)包括亚甲基四氢叶酸还原酶(MTHFR)的C677T(rs1801133)、A1298C(rs1801131),甲基四氢叶酸同型半胱氨酸甲基转移酶/甲硫氨酸合酶(MTR)的A2756G(rs1805087),以及对氧磷酶1(PON1)基因的A192G(rs662),所有这些均通过四引物等位基因特异性突变系统聚合酶链反应(T-ARMS-PCR)进行验证。使用常规PCR分析血管紧张素转换酶(ACE)基因中的插入缺失(I/D;rs4646994)多态性。所有研究性状均通过方差分析(ANOVA)进行审查,随后进行回归分析。通过ANOVA和多重比较,发现CVA与血清同型半胱氨酸、胆固醇以及舒张压读数之间存在关联。当对数据进行回归分析时,血清同型半胱氨酸和舒张压(通过ANOVA具有显著性),以及另外两个性状,即高密度脂蛋白(HDL)和rs1801133 MTHFR SNP在与CVA和中风的关系中保持统计学显著性和显著的优势比。影响脑血管的疾病是多因素的,基因、蛋白质和环境因素都会产生累积效应,增加CVA风险。当前研究强调,SNP和循环生物标志物的变异可用于筛查目的,并用于评估它们在中风/CVA相关风险进展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a41/7938795/2fdd43f0949a/10-1055-s-0041-1722884-i2000021-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a41/7938795/298067e8da36/10-1055-s-0041-1722884-i2000021-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a41/7938795/2fdd43f0949a/10-1055-s-0041-1722884-i2000021-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a41/7938795/298067e8da36/10-1055-s-0041-1722884-i2000021-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a41/7938795/2fdd43f0949a/10-1055-s-0041-1722884-i2000021-2.jpg

相似文献

1
The Connotation of Variances in the Risk Predictors, Medications, Homocysteine, and Homocysteine Pathway Gene Polymorphisms with CVA/Stroke.风险预测指标、药物、同型半胱氨酸及同型半胱氨酸代谢途径基因多态性与CVA/中风的差异内涵
Glob Med Genet. 2020 Dec;7(4):113-120. doi: 10.1055/s-0041-1722884. Epub 2021 Feb 9.
2
The risk stratification of coronary vascular disease as linked to homocysteine, its modulating genes, genetic polymorphisms, conventional predictors, and with antihypertensive medicaments.与同型半胱氨酸、调节基因、遗传多态性、传统预测因子相关的冠状动脉血管疾病风险分层,以及与降压药物的关系。
Chin J Physiol. 2021 Nov-Dec;64(6):298-305. doi: 10.4103/cjp.cjp_71_21.
3
The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease.亚甲基四氢叶酸还原酶(MTHFR)、甲硫氨酸合成酶还原酶(MTR)、血管紧张素转换酶(ACE)基因多态性与高同型半胱氨酸血症的社区关系作为冠心病的潜在危险因素。
Appl Physiol Nutr Metab. 2017 Oct;42(10):1009-1014. doi: 10.1139/apnm-2017-0030. Epub 2017 May 17.
4
Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease.四引物扩增受阻突变体系聚合酶链反应与叶酸/同型半胱氨酸通路基因和 ACE 基因多态性与冠心病的关系。
Mol Cell Biochem. 2011 Sep;355(1-2):289-97. doi: 10.1007/s11010-011-0866-6. Epub 2011 May 13.
5
Dual effect of methylene-tetrahydrofolate reductase and angiotensinconverting enzyme gene polymorphisms on the risk of acute ischemic stroke.亚甲基四氢叶酸还原酶和血管紧张素转换酶基因多态性对急性缺血性脑卒中风险的双重影响。
J Genet. 2023;102.
6
Association between polymorphisms and risk of ischemic stroke.基因多态性与缺血性脑卒中风险的相关性。
Int J Neurosci. 2021 Jan;131(1):44-48. doi: 10.1080/00207454.2020.1733554. Epub 2020 Feb 26.
7
ANALYSIS OF RELATIONSHIP BETWEEN POLYMORPHISM OF MTHFR (C677T), MTHFR (A1298C), MTR (A2756G) GENES IN THE DEVELOPMENT OF ISCHEMIC STROKE IN YOUNG PATIENTS.亚甲基四氢叶酸还原酶(C677T)、亚甲基四氢叶酸还原酶(A1298C)、甲硫氨酸合成酶(A2756G)基因多态性与青年缺血性脑卒中的关系分析。
Georgian Med News. 2021 Oct(319):87-92.
8
Joint associations of folate, homocysteine and MTHFR, MTR and MTRR gene polymorphisms with dyslipidemia in a Chinese hypertensive population: a cross-sectional study.中国高血压人群中叶酸、同型半胱氨酸与MTHFR、MTR和MTRR基因多态性与血脂异常的联合关联:一项横断面研究
Lipids Health Dis. 2015 Sep 4;14:101. doi: 10.1186/s12944-015-0099-x.
9
Association of and Polymorphisms with Serum Homocysteine, Folate and Vitamin B12 in Patients with Young Coronary Artery Disease.年轻冠心病患者中[具体基因]多态性与血清同型半胱氨酸、叶酸及维生素B12的关联
Indian J Clin Biochem. 2022 Apr;37(2):224-231. doi: 10.1007/s12291-021-00982-1. Epub 2021 May 18.
10
Methylene Tetrahydrofolate Reductase (MTHFR) rs868014 Polymorphism Regulated by miR-1203 Associates with Risk and Short Term Outcome of Ischemic Stroke.由miR-1203调控的亚甲基四氢叶酸还原酶(MTHFR)rs868014多态性与缺血性中风的风险及短期预后相关。
Cell Physiol Biochem. 2017;41(2):701-710. doi: 10.1159/000458429. Epub 2017 Feb 8.

本文引用的文献

1
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group.动脉高血压患者的卒中预防:西班牙神经病学学会卒中研究组的建议。
Neurologia (Engl Ed). 2021 Jul-Aug;36(6):462-471. doi: 10.1016/j.nrleng.2020.04.023. Epub 2021 Apr 23.
2
Validity of National Institutes of Health Stroke Scale for Severity of Stroke to Predict Mortality Among Patients Presenting With Symptoms of Stroke.美国国立卫生研究院卒中量表对卒中严重程度的有效性,以预测出现卒中症状患者的死亡率。
Cureus. 2020 Sep 5;12(9):e10255. doi: 10.7759/cureus.10255.
3
Sex-specific cardiac and vascular responses to hypertension in Chinese populations without overt cardiovascular diseases.
中国无明显心血管疾病人群中性别特异性的高血压心脏和血管反应。
Postgrad Med. 2021 Mar;133(2):181-187. doi: 10.1080/00325481.2020.1835037. Epub 2020 Nov 23.
4
Association of Genetic Variants with Hyperhomocysteinemia in Indian Patients with Thrombosis.印度血栓形成患者中基因变异与高同型半胱氨酸血症的关联
Indian J Clin Biochem. 2020 Oct;35(4):465-473. doi: 10.1007/s12291-019-00846-9. Epub 2019 Aug 30.
5
Predictors and Changes of Self-Perceived Burden Among Stroke Survivors: A 3-Month Follow-Up Study.中风幸存者自我感知负担的预测因素及变化:一项为期3个月的随访研究。
Front Neurol. 2020 Jul 24;11:742. doi: 10.3389/fneur.2020.00742. eCollection 2020.
6
Factors associated with long-term survival in patients with stroke after coronary artery bypass grafting.与冠状动脉旁路移植术后脑卒中患者长期生存相关的因素。
J Int Med Res. 2020 Jul;48(7):300060520920428. doi: 10.1177/0300060520920428.
7
Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016.2005 年至 2016 年期间有中风和高血压病史的个体中抗高血压药物使用的趋势。
JAMA Neurol. 2020 Nov 1;77(11):1382-1389. doi: 10.1001/jamaneurol.2020.2499.
8
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial.根据基线白蛋白尿状态和肾功能评估心血管和肾脏结局:LEADER 随机试验结果。
Diabetes Obes Metab. 2020 Nov;22(11):2077-2088. doi: 10.1111/dom.14126. Epub 2020 Aug 7.
9
Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults.他汀类药物的使用与健康老年人的无残疾生存和心血管疾病的关系。
J Am Coll Cardiol. 2020 Jul 7;76(1):17-27. doi: 10.1016/j.jacc.2020.05.016.
10
To whom recommend intensive treatment for hypertension?推荐哪些人接受高血压强化治疗?
Eur Heart J Suppl. 2020 Jun;22(Suppl E):E167-E172. doi: 10.1093/eurheartj/suaa085. Epub 2020 Mar 23.